Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML)

Uy, G.L., Rettig, M.P., Vey, N., Godwin, J., Foster, M.C., Rizzieri, D.A., Arellano, M.L., Topp, M.S., Huls, G., Jongen-Lavrencic, M., Martinelli, G., Paolini, S., Ciceri, F., Carrabba, M.G., Sweet, K.L., Ravandi, F., Church, S.E., Vadakekolathu, J. ORCID: 0000-0002-2671-4285, Rutella, S. ORCID: 0000-0003-1970-7375, Sun, J., Yang, K., Baughman, J., Curtis, T., Timmeny, E., Cali, K., Tran, K., Muth, J., La Motte-Mohs, R., Poirot, C., Pallis, A., Cesano, A., Bonvini, E., Wiggington, J., Lowenberg, B., Davidson-Moncada, J.K. and DiPersio, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Blood
Creators:	Uy, G.L., Rettig, M.P., Vey, N., Godwin, J., Foster, M.C., Rizzieri, D.A., Arellano, M.L., Topp, M.S., Huls, G., Jongen-Lavrencic, M., Martinelli, G., Paolini, S., Ciceri, F., Carrabba, M.G., Sweet, K.L., Ravandi, F., Church, S.E., Vadakekolathu, J., Rutella, S., Sun, J., Yang, K., Baughman, J., Curtis, T., Timmeny, E., Cali, K., Tran, K., Muth, J., La Motte-Mohs, R., Poirot, C., Pallis, A., Cesano, A., Bonvini, E., Wiggington, J., Lowenberg, B., Davidson-Moncada, J.K. and DiPersio, J.F.
Publisher:	American Society of Hematology
Date:	29 November 2018
Volume:	132
Number:	S1
ISSN:	0006-4971
Identifiers:	Number Type 10.1182/blood-2018-99-117085 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	19 Dec 2018 11:02
Last Modified:	04 Feb 2022 16:21
Related URLs:	Publisher
URI:	https://irep.ntu.ac.uk/id/eprint/35386

Actions (login required)

Edit View

Views

Downloads